◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
OncoTherapy Science,Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 10, 2025Q4 2024Nov 11, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
+Operating Income -531.1M -694.8M -- -- -- --
Operating Margin % 97.4% 98.1% -- -- -- --
+Ordinary Income -545.2M -708.2M -- -- -- --
Revenue Growth % 23.0% -- -- -- -- --
Line ItemQ4 2025Nov 10, 2025Q4 2024Nov 11, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
Current Assets 1.1B 817.8M -- -- -- --
Total Assets 1.2B 867.3M 931.2M 2.0B 3.6B 3.7B
Current Liabilities 327.7M 359.6M -- -- -- --
Total Liabilities 426.1M 513.6M 275.0M 373.2M 394.4M 273.9M
Total Equity 729.1M 353.7M 656.1M 1.7B 3.2B 3.5B
Equity Ratio -- -- 0.62 0.79 0.88 0.90
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...